Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
07/2003
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330245A1 Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1433305A Process for recovering statin compounds from fermentation broth
07/30/2003CN1116270C Novel retinoids derivs.
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6599861 Herbicides
07/24/2003US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
07/23/2003EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
07/23/2003CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
07/23/2003CN1431202A Red fluorescence dyestuff and its synthesizing method and usage
07/23/2003CN1115344C Substituted phenyl keto enols derivatives, its prepn. method and use
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/17/2003WO2003057686A1 Alpha-methylenelactone synthesis in supercritical fluids
07/17/2003WO2003057685A1 Luminacin analogs and uses thereof
07/17/2003WO2003057684A1 Process for the preparation of simvastatin
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003CN1430616A Oxidation of ketones to esters using tin substituted zeolith beta
07/16/2003CN1429824A New compound separated from safflower, its preparation method and medical use
07/16/2003CN1114599C Process for preparing dihydropyrane compound
07/10/2003WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s)
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030129712 By reacting heterocyclic ketones with a cyanide donor in the presence of a hydroxynitrile lyase
07/09/2003EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors
07/09/2003EP1324972A1 Dihydroxy open-acid salt of simvastatin
07/09/2003EP1135380B1 Process for the preparation of simvastatin and analogs thereof
07/09/2003CN1429221A 2-phenylpyran-4-one derivatives
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/08/2003CA2280395C New hydroxamic acid derivatives, their preparation process and the pharmaceutical compositions which contain them
07/08/2003CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them
07/03/2003WO2003053347A2 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
07/03/2003US20030125489 Open chain alkoxyamine compounds and their use as polymerization regulators
07/03/2003US20030125366 Phorboxazole derivatives for treating cancer
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof
07/02/2003EP1323830A2 Process for the preparation of heterocyclic (R)- and (S)-cyanohydrines
07/02/2003EP1323715A1 Inhibitors of cholesterol esterase
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
06/2003
06/27/2003CA2415185A1 Process for preparing heterocyclic (r)- and (s)-cyanohydrins
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003051862A1 Process for the preparation of pyranone derivatives
06/26/2003WO2003051830A2 Enantiopure 4-deoxypentenosides, dihydropyrans and tetrahydropyrans and syntheses thereof
06/26/2003WO2003051824A1 α-CYANOACRYLATES
06/26/2003WO2003051823A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides
06/26/2003WO2003051325A1 Skin lightening agents, novel compounds, compositions and use
06/26/2003US20030120086 Such as free acids of mevastatin formed via crystallization with tertiary butylamine; antihypercholesterolemic agents
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003DE10207410C1 Production of 3,6-dihydro-2H-pyran-2-carboxylic esters by thermal hetero-Diels-Alder reaction involves heating glyoxylic esters in absence of catalyst and stabilizer before addition, preferably dosed addition, of diene
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2470156A1 .beta.-amino-.alpha.-cyanoacrylates and their use as herbicides
06/26/2003CA2469716A1 .alpha.-cyanoacrylates
06/25/2003EP1321141A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1077765B1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors
06/25/2003CN1425661A Lactonization processing method in preparing Tating compounds
06/25/2003CN1112343C Skin lightening compositions
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583295 Salts of HMG-CoA reductase inhibitors
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050104A1 Novel substance fki-1083 and process for producing the same
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1056737B1 Process for the preparation of simvastatin and derivatives thereof
06/18/2003CN1425013A Phenyl substituted 4-hydroxy tetrahydropyridone
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/18/2003CN1424910A IL-8 receptor antagonists
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/17/2003CA2046654C Radiolabeled proteins for diagnostic or therapeutic use
06/12/2003WO2003048149A1 Processing method of lactonization in the preparation of statins
06/12/2003WO2003048148A2 Statin-like compounds
06/12/2003US20030109723 Processing method of lactionization in the preparation of statins
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
06/11/2003EP1317440A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives
06/11/2003CN1423629A Metathesis synthesis of pheromones or their components
06/10/2003US6576775 Process for producing simvastatin
06/10/2003US6576771 Pesticides, herbicides and fungicides
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045935A1 Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105158 Hydrates of a neuraminic acid compound and crystalline forms thereof
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/04/2003EP1316552A1 Processing method of lactonization in the preparation of statins
06/04/2003EP1315719A1 Multivalent neuraminidase inhibitor conjugates
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/03/2003US6573392 Synthesis of simvastatin from lovastatin by converting the lovastatin to lova amide using a secondary amine; reaction with metal amide base from n-butyl lithium and pyrrolidine; treatment with methyl iodide to give C-methylated intermediate
06/03/2003US6573385 Process for manufacturing simvastatin and novel intermediates thereof
05/2003
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030099756 Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
05/22/2003US20030097008 Chemical amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 129